These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 20564535)

  • 1. Gut microbial diversity is reduced by the probiotic VSL#3 and correlates with decreased TNBS-induced colitis.
    Uronis JM; Arthur JC; Keku T; Fodor A; Carroll IM; Cruz ML; Appleyard CB; Jobin C
    Inflamm Bowel Dis; 2011 Jan; 17(1):289-97. PubMed ID: 20564535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretreatment with the probiotic VSL#3 delays transition from inflammation to dysplasia in a rat model of colitis-associated cancer.
    Appleyard CB; Cruz ML; Isidro AA; Arthur JC; Jobin C; De Simone C
    Am J Physiol Gastrointest Liver Physiol; 2011 Dec; 301(6):G1004-13. PubMed ID: 21903764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bifidobacterium longum and VSL#3
    Chen X; Fu Y; Wang L; Qian W; Zheng F; Hou X
    Dev Comp Immunol; 2019 Mar; 92():77-86. PubMed ID: 30227219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Probiotic VSL#3 Modulates Colonic Macrophages, Inflammation, and Microflora in Acute Trinitrobenzene Sulfonic Acid Colitis.
    Isidro RA; Lopez A; Cruz ML; Gonzalez Torres MI; Chompre G; Isidro AA; Appleyard CB
    J Histochem Cytochem; 2017 Aug; 65(8):445-461. PubMed ID: 28692320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression profiling identifies mechanisms of protection to recurrent trinitrobenzene sulfonic acid colitis mediated by probiotics.
    Mariman R; Kremer B; van Erk M; Lagerweij T; Koning F; Nagelkerken L
    Inflamm Bowel Dis; 2012 Aug; 18(8):1424-33. PubMed ID: 22162025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Participation of the intestinal microbiota in the mechanism of beneficial effect of treatment with synbiotic Syngut on experimental colitis under stress conditions.
    Konturek PC; Konturek K; Brzozowski T; Wojcik D; Magierowski M; Targosz A; Krzysiek-Maczka G; Sliwowski Z; Strzalka M; Magierowska K; Szczyrk U; Kwiecien S; Ptak-Belowska A; Neurath M; Dieterich W; Wirtz S; Zopf Y
    J Physiol Pharmacol; 2020 Jun; 71(3):. PubMed ID: 32991312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amelioration of DSS-induced murine colitis by VSL#3 supplementation is primarily associated with changes in ileal microbiota composition.
    Mar JS; Nagalingam NA; Song Y; Onizawa M; Lee JW; Lynch SV
    Gut Microbes; 2014 Jul; 5(4):494-503. PubMed ID: 25144681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of TNBS-induced colitis by different Lactobacillus and Bifidobacterium strains is associated with an expansion of gammadeltaT and regulatory T cells of intestinal intraepithelial lymphocytes.
    Roselli M; Finamore A; Nuccitelli S; Carnevali P; Brigidi P; Vitali B; Nobili F; Rami R; Garaguso I; Mengheri E
    Inflamm Bowel Dis; 2009 Oct; 15(10):1526-36. PubMed ID: 19504616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis.
    Kühbacher T; Ott SJ; Helwig U; Mimura T; Rizzello F; Kleessen B; Gionchetti P; Blaut M; Campieri M; Fölsch UR; Kamm MA; Schreiber S
    Gut; 2006 Jun; 55(6):833-41. PubMed ID: 16401690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histamine H2 Receptor-Mediated Suppression of Intestinal Inflammation by Probiotic Lactobacillus reuteri.
    Gao C; Major A; Rendon D; Lugo M; Jackson V; Shi Z; Mori-Akiyama Y; Versalovic J
    mBio; 2015 Dec; 6(6):e01358-15. PubMed ID: 26670383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partially hydrolysed guar gum ameliorates murine intestinal inflammation in association with modulating luminal microbiota and SCFA.
    Takagi T; Naito Y; Higashimura Y; Ushiroda C; Mizushima K; Ohashi Y; Yasukawa Z; Ozeki M; Tokunaga M; Okubo T; Katada K; Kamada K; Uchiyama K; Handa O; Itoh Y; Yoshikawa T
    Br J Nutr; 2016 Oct; 116(7):1199-1205. PubMed ID: 27604176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lactobacillus fermentum CECT 5716 prevents and reverts intestinal damage on TNBS-induced colitis in mice.
    Mañé J; Lorén V; Pedrosa E; Ojanguren I; Xaus J; Cabré E; Domènech E; Gassull MA
    Inflamm Bowel Dis; 2009 Aug; 15(8):1155-63. PubMed ID: 19266568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a probiotic Lactobacillus plantarum TN8 strain on trinitrobenzene sulphonic acid-induced colitis in rats.
    Trabelsi I; Ktari N; Ben Slima S; Hamden K; Ben Salah R
    J Anim Physiol Anim Nutr (Berl); 2017 Apr; 101(2):311-319. PubMed ID: 27435031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VSL#3 probiotic modifies mucosal microbial composition but does not reduce colitis-associated colorectal cancer.
    Arthur JC; Gharaibeh RZ; Uronis JM; Perez-Chanona E; Sha W; Tomkovich S; Mühlbauer M; Fodor AA; Jobin C
    Sci Rep; 2013 Oct; 3():2868. PubMed ID: 24100376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enteric Delivery of Regenerating Family Member 3 alpha Alters the Intestinal Microbiota and Controls Inflammation in Mice With Colitis.
    Darnaud M; Dos Santos A; Gonzalez P; Augui S; Lacoste C; Desterke C; De Hertogh G; Valentino E; Braun E; Zheng J; Boisgard R; Neut C; Dubuquoy L; Chiappini F; Samuel D; Lepage P; Guerrieri F; Doré J; Bréchot C; Moniaux N; Faivre J
    Gastroenterology; 2018 Mar; 154(4):1009-1023.e14. PubMed ID: 29133078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of thalidomide on trinitrobenzene sulfonate-induced colitis in young rats and its mechanism.
    Xu J; Zheng C; Huang Y; Liang Y
    Chin Med J (Engl); 2014; 127(12):2368-75. PubMed ID: 24931258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Divergent Effectiveness of Multispecies Probiotic Preparations on Intestinal Microbiota Structure Depends on Metabolic Properties.
    Biagioli M; Capobianco D; Carino A; Marchianò S; Fiorucci C; Ricci P; Distrutti E; Fiorucci S
    Nutrients; 2019 Feb; 11(2):. PubMed ID: 30717413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventative effects of a probiotic, Lactobacillus salivarius ssp. salivarius, in the TNBS model of rat colitis.
    Peran L; Camuesco D; Comalada M; Nieto A; Concha A; Diaz-Ropero MP; Olivares M; Xaus J; Zarzuelo A; Galvez J
    World J Gastroenterol; 2005 Sep; 11(33):5185-92. PubMed ID: 16127750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probiotic mixture supplementation in the preventive management of trinitrobenzenesulfonic acid-induced inflammation in a murine model.
    Traina G; Menchetti L; Rappa F; Casagrande-Proietti P; Barbato O; Leonardi L; Carini F; Piro F; Brecchia G
    J Biol Regul Homeost Agents; 2016; 30(3):895-901. PubMed ID: 27655518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variable response to probiotics in two models of experimental colitis in rats.
    Shibolet O; Karmeli F; Eliakim R; Swennen E; Brigidi P; Gionchetti P; Campieri M; Morgenstern S; Rachmilewitz D
    Inflamm Bowel Dis; 2002 Nov; 8(6):399-406. PubMed ID: 12454615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.